Aevi Genomic Medicine Current Ratio 2012-2018 | GNMX

Aevi Genomic Medicine current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aevi Genomic Medicine Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.02B $0.01B 3.13
2018-06-30 $0.02B $0.01B 4.05
2018-03-31 $0.03B $0.01B 5.77
2017-12-31 $0.04B $0.00B 8.36
2017-09-30 $0.02B $0.01B 2.32
2017-06-30 $0.02B $0.01B 4.56
2017-03-31 $0.03B $0.01B 5.54
2016-12-31 $0.04B $0.01B 7.20
2016-09-30 $0.05B $0.01B 8.71
2016-06-30 $0.06B $0.00B 13.95
2016-03-31 $0.05B $0.00B 12.57
2015-12-31 $0.05B $0.00B 13.77
2015-09-30 $0.02B $0.01B 1.84
2015-06-30 $0.02B $0.00B 9.33
2015-03-31 $0.03B $0.00B 18.08
2014-12-31 $0.03B $0.00B 9.24
2014-09-30 $0.02B $0.00B 6.03
2014-06-30 $0.02B $0.00B 7.36
2014-03-31 $0.02B $0.00B 6.87
2013-12-31 $0.02B $0.00B 7.50
2013-09-30 $0.03B $0.00B 7.75
2013-06-30 $0.03B $0.00B 13.24
2013-03-31 $0.03B $0.00B 12.38
2012-12-31 $0.01B $0.00B 2.97
2012-09-30 $0.01B $0.00B 4.45
2012-06-30 $0.01B $0.00B 4.96
2012-03-31 $0.00B $0.00B 2.23
2011-12-31 $0.01B $0.00B 2.97
2011-09-30 $0.01B $0.00B 3.79
2011-06-30 $0.01B $0.00B 5.20
2011-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.015B $0.000B
Aevi Genomic Medicine Inc. is focused on genomic medicine. The Company focuses on translating genetic discoveries into novel therapies. Its product candidates include AEVI-001 and AEVI-002 which are in clinical trial stage. Aevi Genomic Medicine Inc., formerly known as Medgenics Inc., is based in WAYNE, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.906B 8.33
Teva Pharmaceutical Industries (TEVA) Israel $18.283B 6.31
Mylan (MYL) United Kingdom $16.418B 6.76
Bausch Health Cos (BHC) Canada $8.901B 6.44
Dr Reddy's Laboratories (RDY) India $5.974B 23.83
Supernus Pharmaceuticals (SUPN) United States $2.043B 19.36
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.817B 3.03
Amphastar Pharmaceuticals (AMPH) United States $1.124B 121.90
Homology Medicines (FIXX) United States $0.916B 0.00
CymaBay Therapeutics (CBAY) United States $0.591B 0.00
Assembly Biosciences (ASMB) United States $0.583B 0.00
Akorn (AKRX) United States $0.557B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.414B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.288B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.092B 0.00
Teligent (TLGT) United States $0.087B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Evoke Pharma (EVOK) United States $0.053B 0.00
Agile Therapeutics (AGRX) United States $0.037B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.017B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00